Prognostic impact of SGLT2 inhibitors in acute decompensated heart failure patients stratified by admission systolic blood pressure: a retrospective cohort study
Abstract Background Sodium–glucose cotransporter-2 inhibitors (SGLT2i) provide cardiovascular benefits in heart failure (HF), but their effectiveness across baseline systolic blood pressure (SBP) levels remains uncertain. This study evaluated the prognostic impact of SGLT2i in hospitalized patients...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2026-04-01
|
| Schriftenreihe: | BMC Cardiovascular Disorders |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12872-026-05869-8 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
